Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
It is paramount to stay vigilant concerning the potential emergence of three newly identified AEs. Significant differences were found in selpercatinib-related AEs concerning reporter continent, sex, weight, dose, frequency, and onset time, which deserved clinical attention. These findings contribute to a broader understanding of the AE profiles of selpercatinib.
Authors
- Cheng Jiang (ORCID: https://orcid.org/0000-0001-8454-749X)
- Shuohan Zhang
- Jiancheng Qian
Institutions
- Tongde Hospital of Zhejiang Province (CN)
- Hangzhou Medical College (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1186/s12885-024-13250-1
- Citations
- 11
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 4.93
Funders
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- Science and Technology Program of Zhejiang Province